Noveris Health Sciences is trading at CA$0.17, down 10.81%, primarily amid sector-wide biotech profit-taking.
- No new company-specific announcement was identified for August 20, 2026.
- The decline follows extreme volatility: a 40.98% drop on August 18 and a 38.64% rebound on August 17.
- Biotech sentiment is cooling after Moderna’s historic rally and Edesa Biotech’s equity offering; rising Treasury yields are also pressuring markets.